| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8955864 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 8 Pages |
Abstract
Dose-escalated prostate SBRT was administered with minimal toxicity in this multi-institutional study. Relapse rates compared favorably with historical controls. SBRT is a suitable option for LR and IR prostate cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Robert M. MD, Daniel A. PhD, Cristian PhD, Alan C. MD, George T. MD, Shermian A. MD, Shirnett K. MD, Najeeb MD, John J. MD, Robert L. MD, David G. MD, Patrick W. MD, Irving D. MD,